Table IV.
Incidence of new/worsening back pain among patients in the monotherapy teriparatide (n = 159) and antiresorptive (n = 265) groups, excluding patients with severe back pain at baseline.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.